Aun Consulting
2459
DMS
9782
Wellco Holdings
7831
Metaplanet
3350
Perseus Proteomics
4882
JP Stock MarketDetailed Quotes
4882 Perseus Proteomics
- 1034
- +150+16.97%
20min DelayMarket Closed Mar 21 15:30 JST
15.24BMarket Cap-11.04P/E (Static)
1034High908Low6.43MVolume910Open884Pre Close6.24BTurnover103452wk High46.50%Turnover Ratio14.74MShares29152wk Low-75.72EPS TTM14.30BFloat Cap1034Historical HighLossP/E (Static)13.83MShs Float255Historical Low-93.69EPS LYR14.25%Amplitude--Dividend TTM8.29P/B100Lot Size--Div YieldTTM
About Perseus Proteomics Company
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.
Company Profile
Symbol4882
Company NamePerseus Proteomics
Founded2001-02-01
MarketTSE Growth
Fiscal Year Ends03-31
Address4-7-6, Komaba Tokyo Park Building, Meguro-ku
Zip Code103-0015
Phone03-6264-8268
Websitewww.ppmx.com
Company Executives
- Name
- Position
- Salary
- Takuya Yokokawa
- Representative Director, President and Executive Officer
- --
- Shinji Hagiwara
- Director, Executive Officer and Head of Business Development Dept and Research and Development
- --
- Shinichi Suzukawa
- Director, Executive Officer and Head of Administrative Dept
- --
- Tatsuya Nagase
- Director
- --
- Takashi Ohno
- Director
- --
- Tadashi Horiuchi
- Independent Director
- --
- Nobuo Hanai
- Independent Director
- --
- Kinichirou Kominami
- Independent Director
- --